Recent Courses

Severe Asthma and the Primary Care Provider: Identifying Patients and...
  • 1.00 AANP credit
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME-accredited Through Your Patient’s EyesTM program is intended for primary care providers and other clinicians who manage patients with asthma. This educational activity has been designed to highlight issues faced by people living with asthma, including patients’ perspectives on the burdens of severe disease, difficulties related to...
Immunotherapy: The Wave of the Future in Bladder Cancer?
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This article reviews the role of immunotherapy in the treatment of locally advanced and metastatic urothelial cell carcinoma (UC). It describes the basic principles of cancer immunotherapy, as they relate to management of UC, and summarizes clinical data on current and investigational therapeutic approaches. Two immune checkpoint inhibitors are...
Real-world Experience With Neuromuscular Blockade Reversal
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Neuromuscular blocking agents (NMBAs) are used in many surgical procedures and have enabled new surgical advances. The expanded landscape of NMB reversal drugs allows for fast and complete neuromuscular blockade (NMB) reversal and the reduction of postoperative complications from residual block. In the United States, neostigmine/ glycopyrrolate...
Perspectives from the American Academy of Dermatology 2017 Meeting: Clinical...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
After many years of little movement in new therapies for patients with atopic dermatitis (AD), significant growth in researching the pathogenesis of AD has resulted in a better understanding of its causes, which has led to new protein targets for novel monoclonal antibodies (mABs). Often diagnosed in infancy, AD can persist into adulthood,...
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era...
  • 2.00 AMA PRA Category 1 Credit(s)™ credits
  • 2.00 Non-physician credits
This educational content was derived from the American College of Physicians (ACP) Internal Medicine Meeting 2017 in San Diego, California. This activity will focus on optimized treatment plans for patients with dyslipidemia in the era of PCSK9 inhibitor therapeutics. LDL-C has been identified as an important therapeutic target to prevent the...
Applying New Science to Improve Outcomes for Patients with Multiple Sclerosis
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will feature content presented at the the 69th Annual American Academy of Neurology (AAN) Meeting held in Boston, Massachusetts. Three expert faculty will analyze recent therapeutic advances in the treatment and management of patients with multiple sclerosis. The clinical relevance of emerging and emerged trial data will be...
Navigating the Evolving Therapeutic Landscape in Advanced Prostate Cancer
  • 3.00 AMA PRA Category 1 Credit(s)™ credits
  • 3.00 Non-physician credits
Statement of Need and PurposeThe treatment of castration-resistant prostate cancer (CRPC) has undergone a rapid evolution over the last decade. Advances in understanding of the mechanisms of CRPC progression have highlighted several pathways and targets that appear promising to better treat this disease.  A number of new therapies from different...
A Therapeutic Update on the Management of Patients with Atopic Dermatitis
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
After many years of little movement in new therapies for patients with atopic dermatitis (AD), significant growth in researching the pathogenesis of AD has resulted in a better understanding of its causes, which has led to new protein targets for novel monoclonal antibodies (mABs). Often diagnosed in infancy, AD can persist into adulthood,...
Updates in Improving Care of Patients With Rheumatoid Arthritis
  • 1.75 AMA PRA Category 1 Credit(s)™ credits
  • 1.75 Non-physician credits
Rheumatoid arthritis (RA) remains a clinically-challenging autoimmune disorder for rheumatologists to manage. Effective patient care is critical: an estimated sixty percent of people with inadequately-treated RA are unable to work 10 years following onset of the disease. The American College of Rheumatology (ACR) has endorsed the use of several...
ACC 2017: A Therapeutic Update to Reduce Risk and Optimize Outcomes for...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This Official Elsevier Clinical Perspectives and Analysis will cover data presented at the American College of Cardiology 66th Annual Scientific Sessions and Expo held in Washington, DC. The four expert faculty will discuss the most up to date statistics and therapeutic advances for patients with preserved ejection fraction heart failure. The...

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.